N-Methyl-1,2-benzenediamine Dihydrochloride: A Key Intermediate for Telmisartan Production
High-purity chemical intermediate for essential pharmaceutical synthesis.
Get a Quote & SampleProduct Core Value

N-Methyl-1,2-benzenediamine dihydrochloride
This compound is a critical building block in the synthesis of Telmisartan, a vital medication for managing hypertension. Its high purity and specific chemical structure make it indispensable for creating effective and safe cardiovascular drugs.
- The synthesis of Telmisartan relies heavily on high-quality intermediates like N-Methyl-1,2-benzenediamine dihydrochloride.
- CAS 25148-68-9 ensures traceability and compliance within the pharmaceutical supply chain.
- Understanding the Telmisartan intermediate market reveals strong demand for reliable suppliers.
- This compound plays a vital role in the production of hypertension medication.
Key Advantages
Exceptional Purity
With an assay of ≥98.5%, this N-Methyl-1,2-benzenediamine dihydrochloride guarantees minimal impurities, crucial for pharmaceutical applications and the efficacy of Telmisartan.
Critical Role in Synthesis
As a key intermediate for Telmisartan synthesis, it facilitates essential chemical reactions, ensuring the quality and consistency of the final drug product.
Reliable Supply Chain
Sourced from reputable manufacturers, it ensures a stable supply chain for pharmaceutical companies, helping to meet the growing global demand for hypertension treatments.
Key Applications
Telmisartan Production
Essential for the multi-step synthesis of Telmisartan, a widely used angiotensin II receptor blocker for hypertension management.
Pharmaceutical Synthesis
Serves as a versatile building block in the creation of other active pharmaceutical ingredients (APIs) requiring similar chemical structures.
Organic Synthesis
Its reactive amine groups and hydrochloride salt form make it valuable for various organic synthesis pathways in research and development.
Cardiovascular Health Products
Contributes to the development and manufacturing of medications that improve cardiovascular health by managing blood pressure.